Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Strides Shasun

Strides Shasun

BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 17, 16:00
916.25
1.15 (0.13%)
VOLUME 13,152
LIVE
NSE
Aug 17, 15:54
916.35
1.6 (0.17%)
VOLUME 188,321
News on Strides Shasun
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Strides Shasun: Outcome of board meeting

1.21 pm | 11 Aug 2017 |  Source: Moneycontrol.com

Outcome of Board Meeting – Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2017...

Strides Shasun's board meeting on August 11, 2017

1.41 pm | 04 Aug 2017 |  Source: Moneycontrol.com

Strides Shasun has informed that the board meeting will be held on August 11, 2017....

Strides Shasun up 2% on USFDA approval for Cetirizine Hydrochloride capsules

12.00 pm | 24 Jul 2017 |  Source: Moneycontrol.com

The product will be manufactured at the company's flagship facility at Bangalore and marketed by Strides Pharma, Inc in the US market....

Strides Shasun gets USFDA nod for anti-allergy capsules

11.23 am | 24 Jul 2017 |  Source: PTI

In a BSE filing, Strides Shasun said, "It has received approval from the US FDA for cetirizine hydrochloride capsules, 10mg (liquid filled capsules OT...

Strides Shasun receives USFDA approval for Cetirizine Softgel capsules

8.58 am | 24 Jul 2017 |  Source: Moneycontrol.com

Strides Shasun has received approval from United States Food & Drug Administration (USFDA) for Cetirizine Hydrochloride capsules, 10 mg....

Key resistance for Nifty at 9969; 4 stocks to buy today: Prakash Gaba 

8.15 am | 24 Jul 2017 |  Source: Moneycontrol.com

According to Prakash Gaba of prakashgaba.com, the next logical technical target for the Nifty is at 9969. The crucial support for the Index is at 9792...

Remain bullish about performance overall in FY18: Strides Shasun 

12.33 pm | 17 Jul 2017 |  Source: CNBC-TV18

Strides Shasun may receive approval for Lovaza generic, which has a market size of around USD 750-800 million in the United Sates and could make upto ...

Buy Strides Shasun; target of Rs 1,200: Axis Direct

1.39 pm | 27 Jun 2017 |  Source: Moneycontrol.com

Axis Direct is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1,200 in its research report dated Jun 22, ...

Buy Strides Shasun; target of Rs 1340: Axis Direct

1.52 pm | 20 Feb 2017 |  Source: Moneycontrol.com

Axis Direct is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1340 in its research report dated February ...

1 2
Quick Links for Strides Shasun
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.